age
Item
aged ≥ 55 years
boolean
C0001779 (UMLS CUI [1])
all
Item
newly diagnosed all without prior treatment
boolean
C0023449 (UMLS CUI [1])
polychemotherapy
Item
patient capable to receive polychemotherapy (who < 2)
boolean
C0013218 (UMLS CUI [1])
meningeal leukemia
Item
with or without meningeal disease
boolean
C0948840 (UMLS CUI [1])
informed consent
Item
signed informed consent forms
boolean
C0021430 (UMLS CUI [1])
social security insurance
Item
subscribed to social security insurance
boolean
C0021682 (UMLS CUI [1])
all t(9;22) and/or bcr-abl positive
Item
all t(9;22) and/or bcr-abl positive
boolean
C0279592 (UMLS CUI [1])
C2861580 (UMLS CUI [2])
general state incompatible with chemotherapy treatment
Item
general state incompatible with chemotherapy treatment (who>2)
boolean
C1298650 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
contraindication
Item
presenting with a general or visceral contraindication to intensive treatment
boolean
C1301624 (UMLS CUI [1])
malignancy
Item
patient with another cancer other than all
boolean
C0006826 (UMLS CUI [1])
communicable disease
Item
severe evolutive infection or hiv seropositive or active hepatitis related to b or c viral infection
boolean
C0009450 (UMLS CUI [1])
l-asparaginase
Item
prior treatment with l-asparaginase (irrespective of the form)
boolean
C0003993 (UMLS CUI [1])
transfusional incident
Item
history of grade 3 transfusional incident (life threatening)
boolean
C0161840 (UMLS CUI [1])
anti-erythrocyte antibodies
Item
presenting rare and/or dangerous anti-erythrocyte antibodies thus leading to the unavailable of a phenotype compatible red blood cells
boolean
C1112584 (UMLS CUI [1])
study subject participation status
Item
included in another clinical trial during the last 4weeks.
boolean
C2348568 (UMLS CUI [1])